Former president and senior vice president of the company were sentenced to nine months in jail and fined $100,000 each, according to the report. The third executive will receive additional jail time. The company violated FDA rules and regulations when surgeons tested its bone cement on patients before the FDA approved it for clinical testing on humans. Three patients died as a result of the procedure.
Related Articles on Spine Devices:
Success in the Spine Market: 6 Spine Company Leaders Discuss the Future
InVivo Therapeutics Reports $3M Net Income
RSB Spine Receives Patent for Spinal Fusion Devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.